Cumberland Pharmaceuticals (CPIX) Invested Capital (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Invested Capital across 17 years of filings, most recently posting $21.3 million for Q1 2026.

• Invested Capital for Q1 2026 came in at $21.3 million, down 24.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.3 million (down 24.83% YoY), and the FY2025 annual result was $24.9 million, down 10.0% from the prior year.
• Invested Capital came in at $21.3 million for Q1 2026 at Cumberland Pharmaceuticals, down from $24.9 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $40.8 million in Q1 2022 to a low of $21.3 million in Q1 2026.
• The 5-year median for Invested Capital is $29.3 million (2023), against an average of $31.3 million.
• Across the five-year window, Invested Capital slipped 29.33% in 2024 and rose 6.33% in 2025, its largest moves.
• Cumberland Pharmaceuticals' Invested Capital stood at $36.0 million in 2022, then fell by 18.66% to $29.3 million in 2023, then retreated by 5.52% to $27.6 million in 2024, then slipped by 10.0% to $24.9 million in 2025, then decreased by 14.38% to $21.3 million in 2026.
• The last three Invested Capital figures came in at $21.3 million (Q1 2026), $24.9 million (Q4 2025), and $25.8 million (Q3 2025), per Business Quant data.